CLSPN
Basic information
Region (hg38): 1:35720218-35769978
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CLSPN gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 81 | 86 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 81 | 7 | 1 |
Variants in CLSPN
This is a list of pathogenic ClinVar variants found in the CLSPN region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-35736524-C-T | not specified | Likely benign (Nov 13, 2023) | ||
1-35736567-G-A | not specified | Uncertain significance (Jan 16, 2025) | ||
1-35736601-C-G | not specified | Uncertain significance (Jun 29, 2023) | ||
1-35736990-C-T | not specified | Uncertain significance (Feb 04, 2025) | ||
1-35736993-G-A | not specified | Uncertain significance (Sep 11, 2024) | ||
1-35737358-C-G | not specified | Uncertain significance (Apr 18, 2023) | ||
1-35737369-A-C | not specified | Uncertain significance (Apr 08, 2024) | ||
1-35737382-A-G | not specified | Uncertain significance (Mar 05, 2025) | ||
1-35737399-C-G | not specified | Uncertain significance (May 15, 2024) | ||
1-35737403-A-G | not specified | Uncertain significance (Dec 12, 2024) | ||
1-35737410-T-C | not specified | Likely benign (Mar 03, 2025) | ||
1-35738037-T-C | not specified | Uncertain significance (Jan 10, 2023) | ||
1-35738071-T-A | Myoepithelial tumor | Uncertain significance (Nov 01, 2022) | ||
1-35738457-T-C | not specified | Uncertain significance (Nov 30, 2022) | ||
1-35738568-T-C | not specified | Uncertain significance (Jun 30, 2024) | ||
1-35739231-C-T | not specified | Uncertain significance (Sep 11, 2024) | ||
1-35739426-C-T | not specified | Uncertain significance (May 13, 2024) | ||
1-35739446-A-G | not specified | Uncertain significance (Jun 16, 2023) | ||
1-35739465-C-T | not specified | Uncertain significance (Jun 17, 2024) | ||
1-35739471-C-T | not specified | Uncertain significance (Sep 10, 2024) | ||
1-35743189-T-A | not specified | Uncertain significance (Mar 11, 2022) | ||
1-35743214-G-C | not specified | Uncertain significance (Nov 07, 2023) | ||
1-35743465-T-C | not specified | Uncertain significance (Mar 17, 2023) | ||
1-35743517-C-T | not specified | Uncertain significance (Sep 07, 2022) | ||
1-35745457-G-A | not specified | Uncertain significance (Nov 16, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CLSPN | protein_coding | protein_coding | ENST00000318121 | 25 | 49750 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00259 | 0.997 | 125591 | 0 | 157 | 125748 | 0.000624 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.854 | 616 | 679 | 0.908 | 0.0000337 | 8905 |
Missense in Polyphen | 173 | 213.18 | 0.81152 | 2822 | ||
Synonymous | -0.0902 | 248 | 246 | 1.01 | 0.0000123 | 2393 |
Loss of Function | 5.61 | 19 | 69.4 | 0.274 | 0.00000381 | 890 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00448 | 0.00445 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000121 | 0.000109 |
Finnish | 0.00255 | 0.00254 |
European (Non-Finnish) | 0.000142 | 0.000141 |
Middle Eastern | 0.000121 | 0.000109 |
South Asian | 0.000196 | 0.000196 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Required for checkpoint mediated cell cycle arrest in response to inhibition of DNA replication or to DNA damage induced by both ionizing and UV irradiation. Adapter protein which binds to BRCA1 and the checkpoint kinase CHEK1 and facilitates the ATR- dependent phosphorylation of both proteins. Can also bind specifically to branched DNA structures and may associate with S- phase chromatin following formation of the pre-replication complex (pre-RC). This may indicate a role for this protein as a sensor which monitors the integrity of DNA replication forks. {ECO:0000269|PubMed:12766152, ECO:0000269|PubMed:15096610, ECO:0000269|PubMed:15190204, ECO:0000269|PubMed:15226314, ECO:0000269|PubMed:15707391}.;
- Pathway
- HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);DNA Repair;DNA Double-Strand Break Repair;Homology Directed Repair;Post-translational protein modification;Metabolism of proteins;Activation of ATR in response to replication stress;G2/M Checkpoints;Cell Cycle Checkpoints;Apoptotic cleavage of cellular proteins;Apoptotic execution phase;Apoptosis;Programmed Cell Death;Ub-specific processing proteases;Deubiquitination;Cell Cycle;PLK1 signaling events;Processing of DNA double-strand break ends;ATR signaling pathway
(Consensus)
Intolerance Scores
- loftool
- 0.701
- rvis_EVS
- 0.74
- rvis_percentile_EVS
- 86.38
Haploinsufficiency Scores
- pHI
- 0.451
- hipred
- Y
- hipred_score
- 0.794
- ghis
- 0.409
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.680
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Clspn
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- DNA damage checkpoint;DNA replication;DNA repair;mitotic G2 DNA damage checkpoint;protein deubiquitination;peptidyl-serine phosphorylation;activation of protein kinase activity;mitotic DNA replication checkpoint
- Cellular component
- nucleoplasm;Golgi apparatus
- Molecular function
- DNA binding;protein binding;anaphase-promoting complex binding